Brazilian beef is a dubious dish for US investors | Lex专栏:美国投资者对巴西牛肉可能并不买账 - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Brazilian beef is a dubious dish for US investors
Lex专栏:美国投资者对巴西牛肉可能并不买账

World’s largest meat processor has long coveted a stateside listing
全球最大的肉类加工商JBS终于获得了监管机构和股东的绿灯,将在美国上市,但投资者不一定买账。
American meat eaters may not have heard of JBS, but chances are they have sampled its wares. Now, the Brazilian meat processor, the largest in the world, wants them to sample its shares, too.
美国肉食者可能没听说过JBS,但很可能品尝过它的产品。现在,这家全球最大的巴西肉类加工企业也希望他们能购买其股票。
JBS supplies much of the beef, pork and poultry that ends up on American plates, and the reliance is mutual. More than half of the $77.2bn in revenue it pulled in last year came from the US. That exposure is one reason the company has long coveted a US share listing. Having pursued the idea on and off for close to a decade, the company finally got the green light from regulators and its shareholders to move its main stock listing from Brazil to the US.
美国人餐桌上的大部分牛肉、猪肉和家禽都是由JBS供应的,这种依赖是相互的。该公司去年772亿美元的收入中有一半以上来自美国。这也是该公司长期以来渴望在美国上市的原因之一。经过近十年断断续续的努力,该公司终于获得了监管机构和股东的绿灯,将其主要股票上市地从巴西转移到了美国。
The company thinks the move will help its stock, which trades at a sharp discount to US rivals, fetch a higher valuation as well as give the company access to cheaper funding.
该公司认为,此举将有助于其股票获得更高的估值——目前其股价与美国竞争对手相比大幅折价——同时还能让公司获得更低成本的融资。
The shares will not be palatable to everyone, though. The founding Batista family, through its investment vehicles, is the largest shareholder in JBS with a 48 per cent stake. The planned issue of supervoting shares, offered disproportionately to the Batista family, could leave it with 85 per cent of votes. 
不过,并非所有人都买账。创始人巴蒂斯塔(Batista)家族通过其投资工具成为JBS的最大股东,持有48%的股份。计划发行的超级投票权股份将以不成比例的方式分配给巴蒂斯塔家族,可能会使其拥有85%的投票权。
Shareholder advisory firms ISS and Glass Lewis both recommended holders of JBS’s current Brazilian shares to vote against the dual listing — to no avail. Long-standing environmental concerns over the impact of cattle ranching on the Amazon rainforest and a bribery scandal that resulted in the US Securities and Exchange Commission hitting JBS and the Batista brothers with multimillion-dollar penalties could keep the shares off the menus of ESG-minded institutional investors.
股东咨询公司ISS和Glass Lewis均建议持有JBS当前巴西股票的股东投票反对双重上市——但未能奏效。长期以来,外界一直担忧养牛业对亚马逊的环境影响,以及一桩贿赂丑闻导致美国证券交易委员会(US Securities and Exchange Commission)对JBS公司及巴蒂斯塔兄弟处以数百万美元罚款,这些因素可能会让注重ESG的机构投资者对该公司股票望而却步。
Even without these oddities, selling meat is a tough business. High grain and cattle prices are driving up costs for meatpackers. A tough economy also means the scope to pass on the higher costs to consumers has become more limited. While 2024 revenue at JBS was up by a fifth since 2021, profitability is 50 per cent lower.
即便没有这些异常情况,肉类销售本身就是一门艰难的生意。高昂的谷物和牲畜价格推高了肉类加工商的成本,而经济不景气也让企业将成本上涨转嫁给消费者的空间变得更小。虽然JBS公司2024年的收入比2021年增长了20%,但盈利能力却下降了一半。
Despite the run-up in share price in the wake of its US listing approval, JBS currently trades on just five times EV to ebitda. By contrast, Tyson Foods is on a multiple of nine times, while Smithfield Foods and Hormel Foods are on seven and 12 times, respectively A US listing, by virtue of potential index inclusion and lower funding costs, should help narrow this valuation gap.
尽管在美国上市获批后股价有所上涨,但目前JBS的企业价值倍数(企业价值与息税折旧摊销前利润(EBITDA)之比)仅为5倍。相比之下,泰森食品公司(Tyson Foods)的为9倍,史密斯菲尔德食品(Smithfield Foods)和荷美尔食品(Hormel Foods)分别为7倍和12倍。
Even then, compared with US rivals, JBS’s business mix leans more towards low-margin beef processing instead of higher-margin processed foods. Acquisitions might help. To close the valuation gap fully, Brazil’s king of beef will have to change much more than its stock market listing.
即便如此,与美国竞争对手相比,JBS的业务结构更偏向于低利润的牛肉加工,而不是高利润的加工食品。收购可能会有所改善。要完全缩小估值差距,这家巴西的牛肉之王需要改变的不仅仅是其股票上市地。
版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
2天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×